Compound information
- Natural Products
- ZC338953
- Molecular Formula
- C12H17ClN2O3S
- Molecular Weight
- 304.064841084 g/mol
- Structure
-
- IUPAC Name
- 2-chloro-N-[4-[isopropyl(methyl)sulfamoyl]phenyl]acetamide
- InChI
- InChI=1S/C12H17ClN2O3S/c1-9(2)15(3)19(17,18)11-6-4-10(5-7-11)14-12(16)8-13/h4-7,9H,8H2,1-3H3,(H,14,16)
- InChI Key
- YUJNROMKMCDRAM-UHFFFAOYSA-N
- SMILES
- CC(C)N(C)S(=O)(=O)c1ccc(NC(=O)CCl)cc1
- Source
- ZINC000008981574
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 66.48 Å2 | LogP | 1.652 |
LogS | -2.736 | LogD | 1.898 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.012 | Pgp substrate | 0.019 |
HIA | 0.964 | F20 % | 0.993 |
F30 % | 0.977 | Caco-2 | -4.952 |
MDCK | -4.912 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.029 | PPB | 75.088 |
VD | 0.992 | Fu | 0.672 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.07 | CYP1A2 substrate | 0.475 |
CYP2A6 substrate | 0.645 | CYP2B6 substrate | 0.577 |
CYP2C19 inhibitor | 0.346 | CYP2C19 substrate | 0.876 |
CYP2C8 substrate | 0.819 | CYP2C9 inhibitor | 0.263 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.223 |
CYP2D6 substrate | 0.886 | CYP2E1 substrate | 0.688 |
CYP3A4 inhibitor | 0.077 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.273 | CL | 9.772 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.237 | Hepatotoxicity | 0.595 |
Mutagenicity | 0.007 | Rat Oral Acute Toxicity | 0.081 |
FDAMDD | 0.035 | Skin Sensitization | 0.922 |
Carcinogenicity | 0.208 | Eye Corrosion | 0.127 |
Eye Irritation | 0.003 | Respiratory Toxicity | 0.873 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.745 | IGC50 | 3.249 |
LC50FM | 3.711 | LC50DM | 3.918 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.128 | NR-AR-LBD | 0.344 |
NR-AhR | 0.3 | NR-Aromatase | 0.773 |
NR-ER | 0.277 | NR-ER-LBD | 0.48 |
NR-PPAR-gamma | 0.884 | SR-ARE | 0.974 |
SR-ATAD5 | 0.501 | SR-HSE | 0.476 |
SR-MMP | 0.308 | SR-p53 | 0.8 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.